# Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy

> **NCT02745106** · PHASE2 · UNKNOWN · sponsor: **Novosibirsk Scientific Research Institute for Circulatory Pathology** · enrollment: 50 (estimated)

## Conditions studied

- Chronic Thromboembolic Pulmonary Hypertension

## Interventions

- **PROCEDURE:** Radiofrequency pulmonary artery denervation
- **DEVICE:** Ablation catheter
- **DEVICE:** Swan-Ganz catheter for right heart catheterization

## Key facts

- **NCT ID:** NCT02745106
- **Lead sponsor:** Novosibirsk Scientific Research Institute for Circulatory Pathology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02745106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02745106, "Interventional Treatment of Residual Pulmonary Hypertension in Patients After Pulmonary Thromboendarterectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02745106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
